Literature DB >> 1090839

Polymyositis and dermatomyositis (first of two parts).

A Bohan, J B Peter.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 1090839     DOI： 10.1056/NEJM197502132920706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1070 in total

1.  Autoantibody profiles in the sera of European patients with myositis.

Authors:  R Brouwer; G J Hengstman; W Vree Egberts; H Ehrfeld; B Bozic; A Ghirardello; G Grøndal; M Hietarinta; D Isenberg; J R Kalden; I Lundberg; H Moutsopoulos; P Roux-Lombard; J Vencovsky; A Wikman; H P Seelig; B G van Engelen ; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

2.  Prevalence in myositis of antibodies recognizing anti-U3 RNA probably in a novel complex with 22/25 kD protein and not fibrillarin.

Authors:  M Kubo; H Ihn; M Kuwana; K Yamane; N Yazawa; K Tamaki
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 3.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 4.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

5.  Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies.

Authors:  Isabela Bruna Pires Borges; Samuel Katsuyuki Shinjo
Journal:  Rheumatol Int       Date:  2018-12-05       Impact factor: 2.631

Review 6.  Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review.

Authors:  Yongpeng Ge; Qinglin Peng; Sigong Zhang; Hang Zhou; Xin Lu; Guochun Wang
Journal:  Clin Rheumatol       Date:  2014-11-01       Impact factor: 2.980

Review 7.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 8.  Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.

Authors:  Li Wang; Li Huang; Yang Yang; Huan Chen; Yanjuan Liu; Ke Liu; Meidong Liu; Yizhi Xiao; Hui Luo; Xiaoxia Zuo; Yisha Li; Xianzhong Xiao; Huali Zhang
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

9.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

10.  Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis.

Authors:  T Fujiyama; T Ito; N Ogawa; T Suda; Y Tokura; H Hashizume
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.